We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

As the government continues its search for a new Drugs Controller General of India (DCGI), it has decided to extend the ...

A team of scientists has developed a groundbreaking approach using specially designed peptides to improve drug formulations.

Researchers at Leipzig University have developed a new process for reversing the polarity of chemical compounds, also known as umpolung, for the precise synthesis of pharmaceuticals. This innovative ...

With each new year comes a new set of accompanying challenges, from tackling the latest innovations to new incarnations of old issues. 2025 will be ...

The US Food and Drug Administration (FDA)’s recently issued final rule establishing application, labeling, and postmarketing reporting ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Teva Pharmaceuticals USA Inc. is taking the Biden administration to court over its drug price negotiation program, days ...

It is possible for the FDA to fast-track drug applications that are high-profile or politically ... to drastically lower ...

Please provide your email address to receive an email when new articles are posted on ... episodes and nighttime blood pressure (BP). The drug’s safety profile in this specific patient ...